T

TScan Therapeutics Inc
NASDAQ:TCRX

Watchlist Manager
TScan Therapeutics Inc
NASDAQ:TCRX
Watchlist
Price: 2.97 USD 1.37% Market Closed
Market Cap: 158.5m USD
Have any thoughts about
TScan Therapeutics Inc?
Write Note

Wall Street
Price Targets

TCRX Price Targets Summary
TScan Therapeutics Inc

Wall Street analysts forecast TCRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TCRX is 12.82 USD with a low forecast of 10.1 USD and a high forecast of 15.75 USD.

Lowest
Price Target
10.1 USD
240% Upside
Average
Price Target
12.82 USD
332% Upside
Highest
Price Target
15.75 USD
430% Upside

TCRX Last Price Targets
TScan Therapeutics Inc

The latest public price target was made on May 16, 2024 by Justin Zelin from BTIG , who expects TCRX stock to rise by 304% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Justin Zelin
BTIG
12 USD
Upside 304%
7 months ago
May 16, 2024
TScan Therapeutics initiated with a Buy at BTIG
TheFly
Justin Zelin
BTIG
Price Target 12 USD
Upside/Downside 304%
View Source
TScan Therapeutics Inc Competitors:
Price Targets
DAWN
Day One Biopharmaceuticals Inc
195% Upside
TVTX
Travere Therapeutics Inc
64% Upside
MGX
Metagenomi Inc
363% Upside
688428
InnoCare Pharma Ltd
34% Upside
BVXP
Bioventix PLC
56% Upside
2256
Abbisko Cayman Ltd
165% Upside
GNS
Genus PLC
59% Upside
ANAB
AnaptysBio Inc
148% Upside

Revenue
Forecast

Revenue Estimate
TScan Therapeutics Inc

For the last 3 years the compound annual growth rate for TScan Therapeutics Inc's revenue is 168%. The projected CAGR for the next 4 years is 10%.

168%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
TScan Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
TScan Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TCRX's stock price target?
Price Target
12.82 USD

According to Wall Street analysts, the average 1-year price target for TCRX is 12.82 USD with a low forecast of 10.1 USD and a high forecast of 15.75 USD.

What is TScan Therapeutics Inc's Revenue forecast?
Projected CAGR
10%

For the last 3 years the compound annual growth rate for TScan Therapeutics Inc's revenue is 168%. The projected CAGR for the next 4 years is 10%.

Back to Top